Journal of Clinical Densitometry
Volume 13, Issue 1 , Pages 77-83 , January 2010

Quantitative Ultrasound and Dual-Energy X-ray Absorptiometry in Children and Adolescents With Neurofibromatosis of Type 1

  • Carla Caffarelli

      Affiliations

    • Department of Internal Medicine, Endocrine-Metabolic Science and Biochemistry, University of Siena, Siena, Italy
    • ,
  • Stefano Gonnelli

      Affiliations

    • Department of Internal Medicine, Endocrine-Metabolic Science and Biochemistry, University of Siena, Siena, Italy
    • Corresponding Author InformationAddress correspondence to: Stefano Gonnelli, MD, Department of Internal Medicine, Endocrine-Metabolic Science and Biochemistry, University of Siena, Policlinico Le Scotte, Viale Bracci 2, 53100 Siena, Italy.
    • ,
  • Loredana Tanzilli

      Affiliations

    • Department of Internal Medicine, Endocrine-Metabolic Science and Biochemistry, University of Siena, Siena, Italy
    • ,
  • Rossella Vivarelli

      Affiliations

    • Department of Pediatrics, Obstetrics, and Reproductive Medicine, University of Siena, Siena, Italy
    • ,
  • Silvia Tamburello

      Affiliations

    • Department of Pediatrics, Obstetrics, and Reproductive Medicine, University of Siena, Siena, Italy
    • ,
  • Paolo Balestri

      Affiliations

    • Department of Pediatrics, Obstetrics, and Reproductive Medicine, University of Siena, Siena, Italy
    • ,
  • Ranuccio Nuti

      Affiliations

    • Department of Internal Medicine, Endocrine-Metabolic Science and Biochemistry, University of Siena, Siena, Italy

Received 26 March 2009 ,Revised 22 October 2009 ,Accepted 24 October 2009.

References 

  1. Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 2007;6:340–351
  2. Schindeler A, Little DG. Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1). Bone. 2008;42:616–622
  3. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45:575–578
  4. Crawford AH, Schorry EK. Neurofibromatosis in children: the role of the orthopaedist. J Am Acad Orthop Surg. 1999;7:217–230
  5. Vitale MG, Guha A, Skaggs DL. Orthopaedic manifestations of neurofibromatosis in children: an update. Clin Orthop Relat Res. 2002;401:107–118
  6. Kuorilehto T, Pöyhönen M, Bloigu R, et al. Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int. 2005;16:928–936
  7. Tsirikos AI, Saifuddin A, Noordeen MH. Spinal deformity in neurofibromatosis type-1: diagnosis and treatment. Eur Spine J. 2005;14:427–439
  8. Kim HW, Weinstein SL. Spine update. The management of scoliosis in neurofibromatosis. Spine. 1997;22:2770–2776
  9. Gilbert A, Brockman R. Congenital pseudarthrosis of the tibia. Long-term follow-up of 29 cases treated by microvascular bone transfer. Clin Orthop Relat Res. 1995;314:37–44
  10. Duman O, Ozdem S, Turkkahraman D, et al. Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1. Brain Dev. 2008;30:584–588
  11. Gluer CC for the International Quantitative Ultrasound Consensus Group. Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. J Bone Miner Res. 1997;12:1280–1288
  12. Baroncelli GI, Federico G, Vignolo M, et al. and the Phalangeal Quantitative Ultrasound Group Cross-sectional reference data for phalangeal quantitative ultrasound from early childhood to young-adulthood according to gender, age, skeletal growth, and pubertal development. Bone. 2006;39:159–173
  13. Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res. 1992;7:137–145
  14. Lu PW, Cowell CT, LLoyd-Jones SA, et al. Volumetric bone mineral density in normal subjects, aged 5-27 years. J Clin Endocrinol Metab. 1996;81:1586–1590
  15. Ward KA, Ashby RL, Roberts SA, et al. UK reference data for the Hologic QDR Discovery dual energy X-ray absorptiometry scanner in healthy children aged 6 -17 years. Arch Dis Child. 2007;92:53–59
  16. Vignolo M, Parodi A, Mascagni A, et al. Longitudinal assessment of bone quality by quantitative ultrasonography in children and adolescents. Ultrasound Med Biol. 2006;32:1003–1010
  17. Wuster C, Albanese C, De Aloysio D, et al. The Phalangeal Osteosonogrammetry Study Group Phalangeal osteosonogrammetry study: age-related changes, diagnostic sensitivity, and discrimination power. J Bone Miner Res. 2000;15:1603–1614
  18. Montagnani A, Gonnelli S, Cepollaro C, et al. Graphic trace analysis of quantitative ultrasound at phalanxes seems to improve the diagnosis of primary hyperparathyroidism among patients with low bone mass. Osteoporos Int. 2002;13:222–227
  19. Barkmann R, Lusse S, Stampa B, et al. Assessment of the geometry of human finger phalanges using quantitative ultrasound in vivo. Osteoporos Int. 2000;11:745–755
  20. Baim S, Leonard MB, Bianchi ML, et al. Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom. 2008;11:6–21
  21. Illés T, Halmai V, de Jonge T, Dubousset J. Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos Int. 2001;12:823–827
  22. Stevenson DA, Moyer-Mileur LJ, Murray M, et al. Bone mineral density in children and adolescents with neurofibromatosis type 1. J Pediatr. 2007;150:83–88
  23. Yilmaz K, Ozmen M, Bora Goksan S, Eskiyurt N. Bone mineral density in children with neurofibromatosis 1. Acta Paediatr. 2007;96:1220–1222
  24. Dulai S, Briody J, Schindeler A, et al. Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort. J Pediatr Orthop. 2007;27:472–475
  25. Lammert M, Kappler M, Mautner VF, et al. Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int. 2005;16:1161–1166
  26. Tucker T, Schnabel C, Hartmann M, et al. Bone health and fracture rate in individuals with NF1. J Med Genet. 2009;46:259–265
  27. Brunetti-Pierri N, Doty SB, Hicks J, et al. Generalized metabolic bone disease in neurofibromatosis type I. Mol Genet Metab. 2008;94:105–111
  28. Baroncelli GI. Quantitative ultrasound methods to assess bone mineral status in children: technical characteristics, performance, and clinical application. Pediatr Res. 2008;63:220–228
  29. Schalamon J, Singer G, Schwantzer G, Nietosvaara Y. Quantitative ultrasound assessment in children with fractures. J Bone Miner Res. 2004;19:1276–1279
  30. Fielding KT, Nix DA, Bachrach LK. Comparison of calcaneus ultrasound and dual X-ray absorptiometry in children at risk of osteopenia. J Clin Densitom. 2003;6:7–15
  31. Baroncelli GI, Federico G, Bertelloni S, et al. Assessment of bone quality by quantitative ultrasound of proximal phalanges of the hand and fracture rate in children and adolescents with bone and mineral disorders. Pediatr Res. 2003;54:125–136

PII: S1094-6950(09)00264-9

doi: 10.1016/j.jocd.2009.10.002

Journal of Clinical Densitometry
Volume 13, Issue 1 , Pages 77-83 , January 2010

Article Tools

* Image Usage & Resolution